Search results
The Glaucoma Foundation
Newswise· 22 hours agoThe Glaucoma FoundationNews, press releases, and expert sources for journalists in science, medicine & business
Former Red Arrow urges eye checks for glaucoma
BBC News· 2 days agoA former Red Arrows' pilot who has an eye condition that can lead to sight loss is urging people to get tested early to ensure it is caught. Martin...
Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
Investor's Business Daily· 4 days agoSkye stock plunged to its lowest-ever point Monday after the biotech company scrapped its failed...
Invasive eye operations should be left up to surgeons. Ohio Bill a dangerous to your sight.
The Columbus Dispatch via Yahoo News· 23 hours agoDr. Elizabeth Muennich is president of the Ohio State Medical Association in Mason. If you needed...
New Research from GRF-funded Investigators Reports | Newswise
Newswise· 4 days agoThe research was made possible through the Catalyst for a Cure Vision Restoration Initiative (CFC3)...
Lexapro: Everything You Need to Know About Its Side Effects
MediaFeed via AOL· 5 days agoStarting a new medication for your mental health can be a time full of uncertainty. And there’s a...
New therapy for glaucoma patients available
WINK TV Southwest Florida· 3 days agoAs that pressure increases, it affects the optic nerve at the back of the eye. “Basically, you kind of see peripheral vision loss, and you start getting tunnel vision,” said Tasneem Sharma, ...
Skye Bioscience ends eye disease R&D efforts after glaucoma drug’s phase 2 fail
FierceBiotech· 5 days agoAs recently as April, Skye had been attributing its work getting SBI-100 into the phase 2...
Skye Bioscience to stop eye disease drug development after failing mid-stage study
Reuters· 5 days ago, opens new tab said on Monday it would discontinue development of its experimental eye disease treatment after the drug failed to meet the main goal of a mid-stage study, dragging its shares ...
Glaukos to repurchase $230M in convertible notes By Investing.com
Investing.com· 18 hours agoGlaukos Corporation (NYSE: NYSE:GKOS), a company specializing in ophthalmic medical technology and...
